Referral for cancer genetics consultation: a review and compilation of risk assessment criteria
about
Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable eventsAnalysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma PatientsGenetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineClinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans.The recurrence risk of genetic complex diseases.Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Primary care physicians' use of family history for cancer risk assessment.The Swedish family-cancer database: update, application to colorectal cancer and clinical relevance.The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence.Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites.Diagnostic criteria for monoclonal B-cell lymphocytosis.A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancerThe evolution of colorectal cancer genetics-Part 1: from discovery to practicePopulation screening for hereditary and familial cancer syndromes in Valka district of LatviaAwareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicityIngredients for success: a familial cancer clinic in an oncology practice setting.Hereditary cancer risk assessment: essential tools for a better approach.Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial.Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.Colorectal cancer screening in 3 racial groups.Cancer Visibility among Iranian Familial Networks: To What Extent Can We Rely on Family History Reports?BRCA Testing in Serbia and Montenegro.Contribution of extended family history in assessment of risk for breast and colon cancer.Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and AttendanceNext-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings"Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma".Familial risk of early and late onset cancer: nationwide prospective cohort studyBreast cancer susceptibility testing: past, present and future.Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study.Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing."You don't have to keep everything on paper": African American women's use of family health history tools.Exploring hereditary cancer among dying cancer patients--a cross-sectional study of hereditary risk and perceived awareness of DNA testing and banking.Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice InitiativeDeveloping Family Healthware, a family history screening tool to prevent common chronic diseases.Interviews with primary care physicians regarding taking and interpreting the cancer family history.Do people really know what makes a family history of cancer?Development and validation of pedigree classification criteria for frontotemporal lobar degeneration.Development and validation of a primary care-based family health history and decision support program (MeTree).Breast and ovarian cancer: the forgotten paternal contribution.
P2860
Q24795928-0082D992-3658-4E0F-8FE2-9F63CDDB6FA7Q30382522-635B0D3D-1CCD-4BB8-940E-17F9F058C910Q30513982-71489FE2-09FF-4993-B72F-53709EE0FB24Q30974845-70596085-8C42-477E-B3FF-6427765CC0E2Q33561021-71EF7246-0CD6-4E50-AC7E-74A36A131BA4Q33564013-7734ED0E-C249-45CC-86E0-E81727440E45Q33595143-71717B45-E0DA-4CE5-84A3-127799099D61Q33721594-165D0E38-B7BF-480A-B014-790CC31F415BQ33722592-C0AE2888-E4C8-4FBC-8990-FAEF255469EBQ33730640-03160692-9FE0-4525-9245-D8947A2F8AEDQ33988895-E94C6432-0415-484A-B1E6-556ABA80484FQ34112119-CD946B2F-64FE-41AF-A5CD-B07100138734Q34234956-869CF87F-EA16-4BC4-A8F3-3577C8D6D430Q34297189-BDC17738-493B-4DBB-A117-00964DC95F67Q34311421-5C15567E-BAA0-47E0-B0AA-64A2C05BB255Q34459715-5ACBEE27-CFCC-4A4D-8A80-9425E011FC6BQ34507839-E912A65F-9CE7-459E-A950-D5EE80DEEC9BQ34722886-F2BBD335-290E-49B4-8666-5954C719920CQ34894629-473E78DB-2539-466B-ADBC-0370474A0A6CQ35447110-278706B0-EBB7-4AA0-90D8-292E0346A8F2Q35734966-66E01846-1DAF-4F40-BA73-C3B473703655Q35755649-A2734BBF-517F-45C9-A908-D2CCAF508769Q36108151-F61BA6B5-F8E1-4A40-99F3-6D0DAF7B34ECQ36118708-731BAFEA-7CBE-421A-A7AB-0726529FE0DAQ36118808-48A2B132-D6A9-442C-8203-5A06312C01A7Q36367741-C0973185-F436-447E-BFE5-0CAFE155E8C2Q36446311-B022C7D8-5DD8-4C77-950A-8BFB668C0C90Q36481037-67EEB572-1620-4415-8604-BF4DD295B40EQ36573827-ADFDD3C1-9ACE-4DC7-A720-C3943387339EQ36613647-D90335F0-8FCD-4EA3-B5D4-7D7A485E5C88Q36849670-011AD45B-1F77-4EE5-8E99-B8F73FCCE27BQ36884576-89B56163-DA2B-4120-900F-2A5EF3D07A91Q36916232-3A87C4B2-0997-48BD-B570-4AA745D406BDQ36925179-54651D74-A826-4A40-971E-5828FABC2DBCQ37102032-DC034E21-FFA6-4600-ACAF-5DC4BD21C4CFQ37292981-DA8426B4-CFFC-4ED8-AF30-DA7DB91F0E8FQ37333708-26F03A00-A4A1-47F9-AE28-FAB3A2F9393AQ37531130-8E3B4C54-BE95-4C45-BFCA-C20D3A090887Q37560024-33FEE877-A05F-49C1-9F01-C2B319EEBD5CQ37866706-119B97C7-F3B7-4F7D-A7D2-34A464BDCB1D
P2860
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Referral for cancer genetics c ...... on of risk assessment criteria
@ast
Referral for cancer genetics c ...... on of risk assessment criteria
@en
type
label
Referral for cancer genetics c ...... on of risk assessment criteria
@ast
Referral for cancer genetics c ...... on of risk assessment criteria
@en
prefLabel
Referral for cancer genetics c ...... on of risk assessment criteria
@ast
Referral for cancer genetics c ...... on of risk assessment criteria
@en
P2093
P2860
P356
P1476
Referral for cancer genetics c ...... on of risk assessment criteria
@en
P2093
P2860
P356
10.1136/JMG.2003.010918
P407
P577
2004-02-01T00:00:00Z